The European Association of Preventive Cardiology reviewed various online risk prediction algorithms and considers advantages and caveats, and gives guidance on which tool to use for which patient.

The LIFE-CVD model can assess 10-year and lifetime CVD risk and life-years gained free from CVD and the effect of interventions in apparently healthy people.

The PCP-HF score provides sex- and race-specific estimates of 10-year risk of incident HF, based on risk factor information readily available in primary care setting.

An analysis of the ADVANCE study shows that the treatment effect of perindopril-indapamide in patients with diabetes is independent of SBP, DBP or 10-year ASCVD risk at baseline.

Comprehensive joint and stratified analyses on sitting, physical activity and all-cause or CV mortality risk evaluated the effects of replacing sitting with various physical activity patterns on mortality risk. With poll.

Bleeding on probing, increased probing pocket depth, caries or fillings in childhood were associated with increased IMT 27 years later, independent of cumulative exposure to CV risk factors.

In a study that aimed to address the healthy donor effect, women who had frequently donated blood in the first 10 years of their donation career, showed fewer CV events than those less often donating.

EPCCS 2019 Slides prepared and presented by prof. Richard Hobbs (Oxford, United Kingdom), here offered as an educational service.

A prospective, accelerometer-based study shows that total sedentary time and the pattern in which it accumulates (long bouts vs interrupted) are positively associated with the risk of CVD in older women.

Large population-based study with 10 years follow-up showed that frequent tooth brushing and regular dental visits lower the risk of CV events associated with oral health problems.

Learn more about the activities of EPCCS that are aimed at supporting primary care professionals manage their patients with cardiovascular and cardiometabolic disease.

A meta-analysis including recent trials and data of over 157.000 individuals shows no benefit of aspirin for primary CV prevention, and a higher risk of major bleeding and intracranial hemorrhage